Increased expression of interferon (IFN)-inducible genes is implicated in the pathogenesis of systemic lupus erythematosus (SLE). One transcription factor responsible for regulating IFN, interferon regulatory factor-5 (IRF5), has been associated with SLE in genetic studies of Asian, Caucasian and Hispanic populations. We genotyped up to seven polymorphic loci in or near IRF5 in a total of 4870 African-American and Caucasian subjects (1829 SLE sporadic cases and 3041 controls) from two independent studies. Population-based case-control comparisons were performed using the Pearson's w 2 -test statistics and haplotypes were inferred using HaploView. We observed significant novel associations with the IRF5 variants rs2004640 and rs3807306 in African Americans and replicated previously reported associations in Caucasians. While we identified risk haplotypes, the majority of haplotypic effects were accounted for by one SNP (rs3807306) in conditional analyses. We conclude that genetic variants of IRF5 associate with SLE in multiple populations, providing evidence that IRF5 is likely to be a crucial component in SLE pathogenesis among multiple ethnic groups.
Introduction
Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by loss of tolerance to nuclear antigens, immune complex deposition and tissue destruction. SLE is present in approximately 1/2500 people and is nine times more prevalent among women. 1 It has an earlier onset, more severe disease manifestations and a four times higher prevalence in African Americans compared to Caucasians in the United States. 2, 3 The diagnosis of SLE requires the presence of 4 of 11 defined criteria of the American College of Rheumatology (ACR), lacking a defined etiology. 4, 5 Both genetic and environmental factors have been suggested as causative agents for the pathogenesis and variable clinical manifestations of SLE. Case-control association studies implicate numerous candidate gene loci. 6 In addition, medications, ultraviolet radiation exposure and infectious pathogens are possible environmental contributors to SLE etiology. 7, 8 Patients with SLE often show increased expression of interferon (IFN)-inducible genes, the presence of which can correlate with more severe disease manifestations such as neurological, renal or hematological involvement. 9 Interferon regulatory factor-5 (IRF5), a transcription factor, regulates the expression of IFN-a genes, 10, 11 thus making it a good candidate gene for SLE susceptibility. Recent publications have reported a significant association between single nucleotide polymorphisms (SNPs) and haplotypes of IRF5 and SLE, both in familyand population-based studies of patients from multiple ethnicities [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] (including meta-analyses) 16 ; however, these studies have not examined African Americans.
Ethnic-specific association studies are necessary to confirm the applicability of previous results to multiple populations because approximately 8% of genetic variation is due to population differences 22 and patterns of linkage disequilibrium (LD) can vary markedly by ethnic group. 23 Minor allele frequencies of many SNPs differ substantially between populations, allowing alleles, when expanded in frequency within one group, more chances to confer greater genetic susceptibility in that one particular population. 24 Examples of ethnic-specific differences in SLE genetic association studies include an association of the p53 gene in Koreans 25 that did not replicate in a Spanish Caucasian population, 26 an association of the heat-shock-protein-encoding gene, HSP70, in Spaniards and Africans but not in Mexicans 27 and the varying levels of significance of CTLA4 associated with SLE in Asians and Europeans. 28 There are even differences in levels of significance within association studies of IRF5 and SLE, such as with studies of Caucasian, 12, 14, [17] [18] [19] Hispanic (Mexican) 15 and Asian subjects. 16 In this report, we evaluate genetic associations of IRF5 with SLE in independent studies (Oklahoma Medical Research Foundation (OMRF) and 'Cases of SLE' (CASSLE) based at the University of Alabama at Birmingham (UAB)) comprised of African-American and Caucasian patients and controls (n ¼ 4870). We replicate the previous associations of IRF5 with SLE found in multiple Caucasian populations and report novel findings of associations in African Americans. Our results highlight the need to determine ethnic-specific differences in genetic association studies and confirm the importance of IRF5 in the pathogenesis of SLE across multiple ethnic groups.
Results

Association of SLE and IRF5 variants
To determine if IRF5 variants associate with SLE in African Americans, we genotyped up to seven variants in two independent sporadic SLE case-control studies (Table 1) . We detected significant associations with the minor T allele at rs2004640 (P ¼ 0.0008) and the minor A allele at rs3807306 (P ¼ 0.02) in the OMRF participants. We replicated the association at rs3807306 (P ¼ 0.008) in CASSLE and found suggestive associations at rs2070197 (P ¼ 0.02) and rs10954213 (P ¼ 0.03). When combining the two for more power, the most significant associations were observed at rs2004640 (P ¼ 0.0001) and rs3807306 (P ¼ 0.0002).
In Caucasians, we replicated the effects previously reported. 12, 14, [17] [18] [19] Similar to African Americans, we again found the strongest associations at rs2004640 (P ¼ 2.2 Â 10
À9
) and rs3807306 (P ¼ 3.0 Â 10 À9 ) in both OMRF and CASSLE and in both studies combined. Allele frequencies were similar to Caucasian populations previously reported (Table 2 ). In the Caucasian populations, the T (rs2004640) and A (rs3807306) risk alleles were the major alleles.
IRF5 haplotype analysis
The haplotype structure of IRF5 is unknown in African Americans. Accordingly, in samples from the AfricanAmerican CASSLE subjects, we performed haplotype analysis using five variants of IRF5 (rs2004640-rs752637-rs3807306-rs10954213-rs2280714). We excluded rs729302 from the haplotype analysis because of its large physical distance and low LD from the other IRF5 SNPs (D 0 ¼ 0.16) and rs2070197 because of its low minor allele frequency in African Americans (0.02). We observed a significant haplotype (TGAAA) determined by the minor A risk allele at rs3807306 (haplotype frequencies (HF) ¼ 0.39 cases and 0.32 controls) ( Table 3) . Using multivariate analysis, it was evident that rs3807306 was responsible for the majority of the observed association with SLE because all other variants individually and the haplotype as a unit lost significance when conditioned on rs3807306 (P ¼ 0.06) ( Table 4 ). In Caucasians, significance was again produced with the same five-marker haplotype (TGAAA) (P ¼ 2.4 Â 10
À7
; odds ratio (OR) ¼ 1.5 (1.3-1.8); HF ¼ 0.53 cases and 0.43 controls). After dropping rs752637 from this haplotype analysis due to Hardy-Weinberg disequilibrium in Caucasians, the remaining four markers still demonstrated significant association (P ¼ 1.6 Â 10 Table 3) . We also observed two protective haplotypes, both driven by the non-risk alleles at rs2004640 (G) and rs3807306 (C) that when combined produce (P ¼ 0.0002 (OR ¼ 0.8) (0.7-0.9); HF ¼ 0.39 cases and 0.48 controls). We noticed differences in haplotypes block structure between ethnicities particularly in regard to the highly associated SNP rs3807306 ( Figure 1 ).
We also tested the previously identified SLE risk threemarker haplotype (rs2004640-rs2070197-rs10954213) in the CASSLE subjects. 13 In African Americans, we observed a marginal protective effect with the GTG haplotype (P ¼ 0.03; HF ¼ 0.39 cases and 0.45 controls). The risk TCA haplotype was observed, but its frequency was extremely low (P ¼ 0.01; OR ¼ 1.9 (1.1-3.5); HF ¼ 0.04 cases and 0.02 controls). Again, when conditioned upon, rs3807306 removed all other associations within the haplotype. In Caucasians, we observed an association with the risk TCA haplotype (P ¼ 0.0004) and the protective GTG haplotype (P ¼ 0.001); however, we did not observe significance with the previously reported GTA protective haplotype 13 (Table 5) . HF using these loci from a previous study are also provided in Table 5 for comparison. 13 
Discussion
IRF5 association with SLE in Caucasian populations was initially reported when evaluating genes of the type I IFN pathway in participants from Sweden and Finland. 18 Since then, several additional studies have evaluated the association between IRF5 and SLE in Caucasian, [12] [13] [14] 17, 19 Korean 16 and Hispanic (Mexican) 15 populations, emphasizing the importance of this gene in SLE etiology. However, no studies have been reported to date in African Americans.
In the present study, we evaluated seven variants of IRF5 for genetic association with SLE using populationbased case-control association designs in African Americans and Caucasians. We establish association of IRF5 with SLE in African Americans using independent studies. The most significant associations detected were with rs2004640, which has been associated in every study to date, and with rs3807306, which has been only recently associated in a UK-based study. 17 We also identified a five-marker (rs2004640-rs752637-rs3807306-rs10954213-rs2280714) risk haplotype (TGAAA) in both ethnic groups and determined that its causative effect is due to rs3807306. While five-marker haplotypes containing the non-risk alleles at rs2004640 (G) and rs3807306 (C) confer a strong protective effect in Caucasians (as is consistent with previous reports 12 ), this effect is not present in African Americans. With the previously identified three-marker haplotype, African American and Caucasians show a similar pattern of association.
Since genetic variants in IRF5 have been largely unexplored in African Americans, we set out to determine if genetic association in this population differs significantly from Caucasians. There is precedent for ethnic-specific SLE associations with CRP, 29 PDCD1
30
and TNF. 31 However, our data suggest that effects of IRF5 are common to both ethnicities. Similar results have been reported for IRF5 variants in Hispanics (Mexican), 15 and we have preliminary data on 459 Hispanic SLE patients and 296 matched controls that agree with significant associations at rs2004640 and rs3807306 similar to both African Americans and Caucasians (data not presented). We note that our findings may be limited by false discovery and the possibility that the observed associations might be due to linkage with other polymorphisms not evaluated. We had between 44 and 98% statistical power to detect an OR of 1.3 given the wide range of allele frequencies among controls and assuming a type I error of 0.05. Confirmatory studies among large African-American populations will be required.
To date, three functional IRF5 variants have been identified. The T allele at rs2004640 creates a GT donor splice site for exon 1b, 12 the A allele at rs10954213 results in more stable IRF5 transcripts leading to higher IRF5 levels 17 and a 30-bp insertion/deletion at exon 6 differentiates the ability of IRF5 to initiate transcription of target genes. 13 Genetic associations at these loci may provide clues about which mechanisms cause improper regulation of IFN responses during SLE pathogenesis.
In summary, this is the first study to date to report positive genetic associations between SLE and IRF5 SNPs/haplotypes in African Americans, providing evidence of a common genetic contributor to SLE in various Allele frequencies for rs10488631 are substituted for rs2070197, a marker in strong linkage disequilibrium (LD), in some populations.
populations and demonstrating that IRF5 is a crucial player in SLE pathogenesis in multiple ethnicities.
Participants, materials and methods
Participant recruitment and biological sample collection
We included 4870 participants (1829 sporadic SLE cases and 3041 controls) enrolled with informed consent into the Lupus Genetics Studies at the OMRF as described previously 32 and the CASSLE case-control study collected at UAB (coordinating center), Northwestern University (Chicago, IL, USA), Johns Hopkins University (Baltimore, MD, USA), University of Texas-Houston Health Sciences Center and the University of Puerto Rico (San Juan, PR, USA) ( Table 6 ). OMRF also included 113 cases (51 Caucasians, 62 African Americans) and 82 controls (39 Caucasians, 13 African Americans) provided by the University of Texas Southwestern (UTSW) Medical Center. Ethnicity was self-reported and verified by ethnicity of the grandparents, when known.
Affected individuals were defined as those meeting 4 of the 11 ACR SLE criteria when evaluated by a study physician. 4, 5 Demographics and selected clinical characteristics of the study populations are presented in Table 6 .
Blood or mouthwash samples were collected from each participant, and genomic DNA was isolated and stored using standard methods. All protocols were approved by the Institutional Review Boards at each respective institution.
Genotyping OMRF data were generated using a GoldenGate custom bead array on the Illumina platform (San Diego, CA, USA) at the UTSWMC Microarray Core Facility (Dallas, TX, USA). CASSLE data were generated using TaqMan allelic discrimination assays (Applied Biosystems, Foster City, CA, USA). TaqMan reactions were performed in a 5 ml volume according to the manufacturer's instructions on a 384-well-based ABI7900HT at UAB. Five SNPs were genotyped on all subjects (rs729302, rs2004640, rs752637, rs3807306 and rs2280714), and two SNPs (rs2070197 and rs10954213) were additionally genotyped in CASSLE participants to replicate recent haplotype-based findings in Caucasians. 13, 14, 17 Statistical analyses SNPs were found to be in Hardy-Weinberg equilibrium unless noted otherwise. Population-based case-control comparisons (allelic w 2 -statistics) were calculated using SAS v9.0. Haplotype analyses were conducted using 
